Candel Therapeutics, Inc. CADL Other Assets
Other Assets at other companies
Other financials
Where this comes from
Reported directly by Candel Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssets.
The official record: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Candel Therapeutics, Inc.'s other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Candel Therapeutics, Inc.'s other assets?
- Candel Therapeutics, Inc. (CADL) reported other assets of $108K in Q1 2026.
- How has Candel Therapeutics, Inc.'s other assets changed year-over-year?
- Candel Therapeutics, Inc.'s other assets increased by 86.2% year-over-year, from $58K to $108K.
- What is the long-term trend for Candel Therapeutics, Inc.'s other assets?
- Over 2 years (2023 to 2025), Candel Therapeutics, Inc.'s other assets has grown at a -13.4% compound annual growth rate (CAGR), from $116K to $87K.